Key
Interventional
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Establish the maximum tolerated dose (MTD) of study drug, with and without G-CSF.
Part 1
Yes
United States: Food and Drug Administration
ARRAY-520-101
NCT00462358
April 2007
November 2010
Name | Location |
---|---|
Wayne State University, Karmanos Cancer Institute | Detroit, Michigan |
Marlene and Stewart Greenebaum Cancer Center | Baltimore, Maryland 21201 |